Wellgistics Health Launches Pilot Collaboration with Kare PharmTech for CCM/RPM, Generating 1,500+ Claims
WGRX is trading near its 52-week low of $0.07 (10% above the low) on light trading volume (0.2× avg).
Summary
Wellgistics Health announced a pilot collaboration with Kare PharmTech to integrate its MSO infrastructure for Chronic Care Management (CCM) and Remote Patient Monitoring (RPM) services. The pilot, which leverages Wellgistics' network of over 6,500 independent pharmacies, has already generated more than 1,500 claims. This new business initiative is significant for the micro-cap company, especially following its recent temporary forbearance agreement for $1.77 million in debt, as it targets a large and growing U.S. market for these services. The collaboration with Kare PharmTech, whose founder has a strong track record in healthcare, could provide a much-needed new revenue stream and operational growth. Investors will be watching for further details on the pilot's expansion and its financial contribution to Wellgistics Health.
At the time of this announcement, WGRX was trading at $0.08 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $9.9M. The 52-week trading range was $0.07 to $3.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Access Newswire.